Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Evaluate Accuracy of ThermalytixTM in Detecting Breast Cancer

NCT05650086 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT05650086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05650086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Evaluate Accuracy of ThermalytixTM in Detecting Breast Cancer
Lead sponsor
University of Arizona
Phase
Observational
Overall status
Terminated
Start date
November 15, 2022
Completion date
June 30, 2023
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer